Effectiveness of Pulsed Radiofrequency of the Saphenous Nerve in the Management of Knee Arthroplasty Pain

March 2, 2018 updated by: Carlo Guerrero Nope, Fundación Santa Fe de Bogota

Efectividad de la Radiofrecuencia Pulsada Del Nervio Safeno en el Manejo Del Dolor en Artroplastia de Rodilla

Approximately 40% of patients undergoing total knee arthroplasty develop acute to moderate post operative pain. Furthermore 20-30% develop chronic post operative pain. The objective of this work is to study the effectiveness and safety of pulsed radiofrequency of the saphenous nerve realized during the pre-operative period of total knee arthroplasty. The study design is a randomized, blinded clinical trial. Patients scheduled for total knee arthroplasty are divided into two groups. The first group procedure consists in pre-operative pulsed radiofrequency under ultrasound guidance of the saphenous nerve and standard postoperative pain management by the pain clinic. The second group receives only the standard postoperative pain management by the pain clinic. Patient follow ups are performed 3 times (after 2 weeks, 2 months and 6 months) within a period of 6 months, evaluating pain severity using the VAS.

Study Overview

Detailed Description

Methods

Study Design

Randomized, blinded clinical trial. Patients are divided into two groups, one to saphenous nerve block with pulsed radiofrequency guided by ultrasound is applied plus standard pain management by the Pain Clinic, the other one only standard pain management by the Pain Clinic. A 6-month follow-up is evaluating pain by VAS and function by the WOMAC scale

Objectif

Asses the effectivity and safety of preoperatory saphenous nerve pulsed radiofrecuency in total knee arthroplasty between 2014 and 2015 in the Fundación Santa Fe de Bogotá Hospital.

Statistical Analysis

Sample size was calculated using "Sample Size 1.0". The following parameters where used to calculate the sample size for a clinical trial:

Two tails, type I error independent variables 5%, type II error 20%, outcome variable: visual analogue scale from 0 to 100 mm, with a standard deviation of 10 mm and a relevant clinical difference between groups of 20 mm. Additionally, the WOMAC scale, from 0 to 96 points, with a standard deviation of 17 and a relevant clinical difference of 20 points between groups for the three subscales: pain, rigidity and functional capacity, normalized to 100 points each.

A sample size of 41 patients per group is calculated. An adjustment of 20% to compensate possible losses is applied, to a total of 50 patients per group.

Once gathered, the data is processed using the statistical program "Wizard" version 1.7.17. posteriorly, variables are standardized and a descriptive analysis is performed.

Central tendency and dispersion measures are performed to the continuous variables. Percentage distribution and proportion measures are calculated to the categorical variables.

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients from the Center for Care of Articular Replacements from Fundación Santa Fe University Hospital programed for knee replacement surgery.
  • ASA I-III
  • Informed consent
  • Unilateral Knee Replacement

Exclusion Criteria:

  • Neurologic conditions associated with hyperalgesia or allodynia
  • Cognitive impairment
  • Psychiatric conditions
  • Contraindication for the use of local anesthetics
  • Bleeding disorders
  • Pacemaker or ICD
  • Septic arthritis or any infection in the surgical site
  • Additional surgical procedure during the surgical act

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: No pulsed radiofrequency
Procedure consists of a mock incision at the pulsed radiofrequency needle insertion site and standard perioperative pain management by the pain clinic (femoral catheter and PCA)
A trained anesthesiologist and pain clinician performs a mock incision on the pulsed radiofrequency needle insertion site
Experimental: Pulsed Radiofrequency
Procedure consists in pre-operative pulsed radiofrequency under ultrasound guidance of the saphenous nerve and standard postoperative pain management by the pain clinic (femoral catheter and PCA)
A trained anesthesiologist and pain clinician performs ultrasound guided pulsed radiofrequency on the saphenous nerve of a patient undergoing knee replacement surgery, prior to the beginning of the surgical act.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain 6 months after sugery
Time Frame: 6 months
VAS Pain value 6 months after the knee replacement surgery. The Visual Analog Scale to assess pain ranges from 0mm to 100mm, where 0 is the 'absence of pain' and 100 is 'the worst pain imaginable by the patient'. Lower values in the scale represent a better outcome for the patient.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption during the postoperative period
Time Frame: 3 days
PCA opioid consumption during postoperative days 0 - 3 in morphine equivalents
3 days
Pain on postoperative days 0-3
Time Frame: 3 days
VAS Pain value on day 0, 1, 2 and 3 after the knee replacement surgery. The Visual Analog Scale to assess pain ranges from 0mm to 100mm, where 0 is the 'absence of pain' and 100 is 'the worst pain imaginable by the patient'. Lower values in the scale represent a better outcome for the patient.
3 days
Pain on postoperative week 2
Time Frame: 15 days
VAS Pain value on day 15 after the knee replacement surgery. The Visual Analog Scale to assess pain ranges from 0mm to 100mm, where 0 is the 'absence of pain' and 100 is 'the worst pain imaginable by the patient'. Lower values in the scale represent a better outcome for the patient.
15 days
Pain on postoperative month 2
Time Frame: 2 months
VAS Pain value 2 months after the knee replacement surgery. The Visual Analog Scale to assess pain ranges from 0mm to 100mm, where 0 is the 'absence of pain' and 100 is 'the worst pain imaginable by the patient'. Lower values in the scale represent a better outcome for the patient.
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

February 23, 2018

First Submitted That Met QC Criteria

February 23, 2018

First Posted (Actual)

March 1, 2018

Study Record Updates

Last Update Posted (Actual)

March 6, 2018

Last Update Submitted That Met QC Criteria

March 2, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Mock incision

Subscribe